Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant
|ClinicalTrials.gov Identifier: NCT01758484|
Recruitment Status : Completed
First Posted : January 1, 2013
Last Update Posted : March 2, 2016
|Condition or disease||Intervention/treatment||Phase|
|Hematopoietic/Lymphoid Cancer||Other: palliative care Other: questionnaire administration Procedure: quality-of-life assessment||Not Applicable|
I. Pilot a supportive care intervention that begins prior to transplantation and continues through the acute peritransplant period.
II. Determine the proportion of patients who enroll and the level of comfort / distress of hematopoietic cell transplant (HCT) patients who meet with the supportive care team.
III. Pilot data collection mechanisms and cost retrieval in preparation for a randomized clinical trial.
Patients undergo supportive care consultation before transplantation and at least once monthly while they remain at the transplant center.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||FEASIBILITY OF IMPLEMENTING PRE-TRANSPLANT EVALUATION BY THE SUPPORTIVE CARE TEAM FOR PATIENTS UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES|
|Study Start Date :||April 2013|
|Actual Primary Completion Date :||November 2014|
Experimental: Supportive care (palliative care support)
Patients undergo palliative care support before transplantation and at least once monthly while they remain at the transplant center.
Other: palliative care
Undergo supportive care intervention
Other: questionnaire administration
Procedure: quality-of-life assessment
Other Name: quality of life assessment
- Study participation rates defined as the proportion of patients who consent to enroll [ Time Frame: Up to 5 months ]Will mainly be descriptive.
- Completion time for the supportive care consultation [ Time Frame: Up to 90 days post-treatment ]Will mainly be descriptive.
- Level of comfort / distress attributed to individual parts of the consultation [ Time Frame: Up to 90 days post-treatment ]Will mainly be descriptive. The post-consultation scores measuring level of comfort or distress per topic in the supportive care consultation will be summarized per item.
- Completeness of follow-up data collection, where completeness is defined by the proportion of instrument scores that can be calculated per given time point [ Time Frame: Up to 90 days post-treatment ]Will mainly be descriptive. The completeness of follow-up data collection will be calculated and reported as a proportion of successfully completed scales vs. scales attempted to be collected or completed by patients.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01758484
|United States, Washington|
|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|
|Seattle, Washington, United States, 98109|
|Principal Investigator:||Stephanie Lee||Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|